fda drug shortage semaglutide Injections and the FDA declares semaglutide (Ozempic/Wegovy) shortage
Description
SUSTAINABLE RESULTS
For many individuals, the benefits of improved blood sugar control, cardiovascular risk reduction, or meaningful weight loss may outweigh potential gut-related risks
Ultimately, the researchers wrote that clinical evidence remains limited and mixed, underscoring the need for biomarker-focused human trials. Why might a GLP-1 lower the risk of Alzheimers
Because these were controlled studies, the poor responders weren't simply skipping doses
Shelf life: 2 years
In individuals managing diabetes or obesity, the relationship between cortisol and metabolism becomes even more significant
